Objective-The MC1-R (melanocortin 1 receptor) is expressed by monocytes and macrophages where it mediates antiinflammatory actions. MC1-R also protects against macrophage foam cell formation primarily by promoting cholesterol efflux through the ABCA1 (ATP-binding cassette transporter subfamily A member 1) and ABCG1 (ATP-binding cassette transporter subfamily G member 1). In this study, we aimed to investigate whether global deficiency in MC1-R signaling affects the development of atherosclerosis.
A therosclerosis is a chronic inflammatory disease of largeand medium-sized arteries that gives eventually rise to major cardiovascular complications such as myocardial infarction and stroke. The disease is characterized by the gradual accumulation of cholesterol-containing LDL (low-density lipoprotein) particles in arterial walls, which triggers a multitude of inflammatory responses and consequent entry of leukocytes into the intima. 1 Monocytes and their descendant macrophages are the most abundant leukocyte subsets in atherosclerotic plaques and also the dominant effector cells in the pathogenesis of the disease. 2 In the mouse, lesional macrophages predominantly originate from infiltrating classical Ly6C high monocytes, 3, 4 whereas the nonclassical Ly6C low monocytes are known to patrol the vasculature but enter the lesions less frequently. 5, 6 Monocyte-derived macrophages then populate lesions and ingest lipids, primarily in the form of oxidized LDL, which transforms them into foam cells. Eventually, these cells can undergo apoptosis, which, in combination with defective clearance of cellular debris, contributes to the formation of necrotic core. 7 This is one of the key features of vulnerable plaques that are prone to rupture and cause life-threatening thrombosis.
The melanocortin system has appeared as an intriguing pharmacological target for modulating immune responses in many inflammatory diseases including atherosclerosis. 8, 9 The system consists primarily of melanocortin peptides, derived from the post-translational processing of the precursor molecule POMC (proopiomelanocortin), their cellular receptors, and 2 endogenous antagonists, agouti and agouti-related protein. Proteolytic February 2018 cleavage of the POMC produces melanocortin peptides, namely adrenocorticotropic hormone and α-, β-and γ-melanocytestimulating hormones, which bind to a family of G-proteincoupled melanocortin receptors, named from MC1-R to MC5-R. Of these 5 receptors, MC1-R was the first member of the receptor family to be cloned. 10 MC1-R stimulates eumelanin synthesis in the skin, being the best-characterized genetic determinant of skin and hair color, 11 but it is now clear that its physiological functions extend well beyond the regulation of skin pigmentation. Among other functions, it mediates anti-inflammatory responses in a variety of different leukocytes, but its immunomodulatory role has been studied in most detail in macrophages. 9 Furthermore, we recently identified a new regulatory function for MC1-R in macrophage cholesterol transport. 12 Activation of MC1-R signaling in macrophages suppressed uptake of oxidized LDL, while concomitantly promoting unloading of intracellular cholesterol that initiates a process called reverse cholesterol transport (RCT). Conversely, dysfunctional MC1-R aggravated cholesterol accumulation and foam cell formation in cultured macrophages. In atherosclerotic Apoe −/− (apolipoprotein E deficient) mice, pharmacological targeting of MC1-R reduced plasma cholesterol level and promoted signs of plaque stability. However, it remains to be determined whether loss-of-function of MC1-R causes a reverse phenotype with enhanced atherosclerosis, thus potentially providing evidence that the integrity of the receptor is a decisive factor for the outcome of the disease.
Thus, we set out to determine whether deficiency in MC1-R signaling contributes to the development of atherosclerosis. To this end, we crossed Apoe −/− mice with the recessive yellow Mc1r
e/e mouse that carries a nonfunctional MC1-R because of a single-base deletion mutation 13 and then characterized the plaque phenotype, cholesterol homeostasis, and tissue leukocyte profiles of this mouse model. We here show that a defect in MC1-R signaling enhances atherogenesis and leads to the formation of more advanced plaques.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

MC1-R Deficiency Accelerates Diet-Induced Atherosclerosis in Apoe −/− Mice
To determine the role of MC1-R in the development of atherosclerosis, we generated Apoe −/− Mc1r e/e mice, fed them a highfat diet (HFD) for 12 weeks, and then analyzed atherosclerotic plaque size and composition using wild-type Apoe −/− mice as controls. We observed that Apoe −/− Mc1r e/e mice developed significantly larger atherosclerotic plaques in the aortic sinus ( Figure 1A and 1B). Likewise, total lesion area in the aorta, as evidenced by en face staining, was increased by ≈50% in MC1-R-deficient mice ( Figure 1C and 1D ). Of particular note, quantification of the acellular areas in the aortic sinus plaques revealed markedly increased necrotic cores in these mice ( Figure 1E and 1F ). This finding was accompanied by reduced α-SMA (α-smooth muscle actin) expression and by lower collagen content in the plaques ( Figure 1E and 1G). Plaque macrophage content was increased in Apoe −/− Mc1r e/e mice, but the ratio of phenotypic M1-and M2-type macrophage markers was unchanged ( Figure I in the online-only Data Supplement). In contrast to HFD conditions, Apoe −/− Mc1r e/e mice on a chow diet displayed no change in atherosclerotic lesion area ( Figure II in the online-only Data Supplement). However, in line with the phenotype of HFD-fed mice, necrotic core area was increased in the aortic plaques of Apoe −/− Mc1r e/e mice ( Figure II in the online-only Data Supplement). Plaque collagen content was lower in chow-fed mice compared with HFD mice, but there was no difference between the genotypes in this regard ( Figure II in the online-only Data Supplement). Collectively, these data indicate that MC1-R deficiency enhances atherogenesis in HFD-fed mice and leads to the formation of more vulnerable plaques.
We next performed quantitative (real-time)-polymerase chain reaction (qPCR) analysis for aortic lysates and screened the samples for a selection of genes that are involved in cholesterol transport and plaque stability. This was performed in mice that were fed a normal chow diet or HFD for 4 weeks to identify whether MC1-R deficiency per se causes changes in gene expression or whether an interaction between the gene defect and excess of dietary cholesterol is needed to drive these effects. The 4-week HFD time point was chosen because upregulation of inflammatory markers at the mRNA level is detectable at this early time point. First, we turned our attention to RCT-promoting proteins, namely ABCA1 (ATP-binding cassette transporter subfamily A member 1) and ABCG1 (ATP-binding cassette transporter subfamily G member 1), which were previously shown to be increased by MC1-R activation in macrophages. 12 These transporters mediate cholesterol efflux and thereby facilitate the clearance of excess cholesterol from macrophages. 14 previous results, we found that MC1-R-deficient mice had reduced aortic expression of Abca1 and Abcg1 ( Figure III in the online-only Data Supplement), changes that occurred independent of the diet. Second, we quantified the mRNA levels of plaque stability markers and observed that Acta2 (gene encoding α-SMA) and Col3a1 (collagen type III α 1) were downregulated in MC1-R-deficient mice ( Figure III in the online-only Data Supplement), further supporting the findings of plaque histology. The downregulation of genes was similar in both diet groups of MC1-R-deficient mice.
MC1-R Deficiency Exacerbates HFDInduced Hypercholesterolemia and Hepatic Lipid Accumulation in Apoe −/− Mice
We next investigated whether MC1-R deficiency affects plasma cholesterol levels during early phases of atherosclerosis when shifting from normal chow diet to HFD. Cholesterol measurements revealed that Apoe −/− Mc1r e/e mice are more prone to HFD-induced hypercholesterolemia compared with Apoe −/− mice, but are able to maintain normal cholesterol levels in the absence of excess dietary cholesterol (Figure 2A) . The increase in total cholesterol on HFD was attributable to the elevation in non-HDL cholesterol ( Figure 2B ), namely LDL and VLDL (very-low-density lipoprotein) fractions, whereas HDL cholesterol showed no genotype difference ( Figure 2C ). After 4 weeks of HFD, relative liver weight was also increased in Apoe −/− Mc1r e/e mice ( Figure 2D ). Oil red O staining of liver sections indicated aggravated lipid accumulation in these mice ( Figure 2E ). In support of this finding, quantification of extracted lipids from liver samples showed that Apoe −/− Mc1r e/e mice had more tissue total cholesterol in the HFD state compared with controls ( Figure 2F ).
To identify mechanisms contributing to the increased hypercholesterolemia and hepatic lipid accumulation, we determined the expression levels of genes involved in cholesterol synthesis and transport in the liver. . Furthermore, Abcg5 and Abcg8 mRNA levels were increased by HFD as expected, but Apoe
e/e mice fell short of this compensation and showed significantly less upregulated Abcg5 and Abcg8 levels in the HFD state ( Figure IV in the online-only Data Supplement). We therefore aimed to test whether this reduction has a functional consequence in terms of cholesterol transport efficiency. We performed an in vivo RCT assay by injecting 3H-cholesterolloaded primary macrophages into both genotypes and measured the transport capacity of cholesterol through the RCT pathway. Because Mc1r e/e macrophages have impaired cholesterol efflux, 12 we injected macrophages from Apoe −/− mice to both genotypes to control for possible differences in the initiating step of RCT and to specifically investigate the RCT pathway downstream of macrophage cholesterol efflux. However, RCT to plasma, liver or feces was not significantly changed in Apoe −/− Mc1r e/e ( Figure IV in the online-only Data Supplement). Likewise, total excretion of neutral sterols into the bile and feces was comparable between the genotypes ( Figure 3A and 3B), suggesting that the reduced Abcg5 and Abcg8 mRNA levels do not result in impaired cholesterol excretion in the liver. To investigate other possible causes of hypercholesterolemia, we measured the size and composition of the bile acid pool in the gall bladder and feces by gas-liquid chromatography. These analyses revealed that total bile acids were reduced in the gall bladder bile ( Figure 3C 
Monocyte Dynamics in MC1-R-Deficient Apoe −/− Mice
Because the effects of MC1-R deficiency on leukocyte counts have not been previously explored, we next quantified total leukocytes and different leukocyte subsets in the blood, spleen, and aorta of mice that were fed either a chow diet or HFD for 4 weeks. Given that hypercholesterolemia is known to trigger monocytosis and predominant expansion of Ly6C high monocytes, we focused on quantifying Ly6C high and Ly6C low monocyte subsets. Flow cytometric analyses revealed that Apoe −/− and Apoe −/− Mc1r e/e mice had equal numbers of circulating total leukocytes, lymphocytes, neutrophils, and monocytes ( Figure 4A ). The extent of HFD-induced monocytosis was also similar between the genotypes ( Figure 4A ). Of particular note, MC1-R-deficient mice on chow diet had lower number of blood Ly6C low monocytes ( Figure 4A ). On the other hand, bone marrow of these mice was more sensitive to HFD-induced hypercholesterolemia and displayed exaggerated Ly6C high monocytosis ( Figure VII in the online-only Data Supplement). Considering that ABCA1 and ABCG1 centrally regulate the proliferation of hematopoietic stem and progenitor cells, [15] [16] [17] we analyzed the levels of these transporters in the bone marrow and found that Abcg1 expression was specifically reduced in HFD-fed Apoe −/− Mc1r e/e mice ( Figure  VII in the online-only Data Supplement).
Characterization of splenic reservoir monocytes showed that Apoe −/− Mc1r e/e mice had markedly reduced numbers of Ly6C high monocytes during baseline conditions when mice were fed a normal chow diet ( Figure 4B) . Likewise, the splenic pool of neutrophils was reduced in these mice ( Figure 4B ). After 4 weeks of HFD, monocyte and neutrophil levels were identical between the genotypes ( Figure 4B ). To examine whether MC1-R deficiency affects local cell differentiation or death in the spleen, thereby explaining the reduced cell counts, we quantified the percentage of dead cells among neutrophils and monocytes and the total number of monocyte-derived macrophages and dendritic cells in the spleen of chow-fed mice. However, Apoe −/− Mc1r e/e mice displayed no changes in the tendency for cell death or monocyte differentiation ( Figure 4C through 4E) , suggesting that the monocytes are exiting the spleen and get recruited to sites of inflammation. Immunostaining of the spleen further revealed that CD11b + cells in Apoe −/− Mc1r e/e mice were most notably lost from the subcapsular red pulp ( Figure 4F) , which is the primary site of rapidly recruitable monocytes. 18 Supporting the notion of enhanced deployment of splenic monocytes, we observed that MC1-R-deficient mice were accumulating more leukocytes in the aorta during chow-fed conditions. This difference was largely attributable to increases in aortic Ly6C high monocyte and macrophage counts ( Figure 4G ). The phenotype was lost when mice were challenged with HFD ( Figure 4G ). Cytokine screening of the plasma of chow-fed mice uncovered that Apoe −/− Mc1r e/e mice indeed showed signs of increased inflammation with significant peaking of IL-1β (interleukin-1β), IL-5, IFN-γ (interferon-γ), TNF-α (tumor necrosis factor-α), and CCL2 (chemokine (C-C motif) ligand 2; Figure VIII in the online-only Data Supplement). CCL2 conveys chemotactic signal specifically for monocytes and is likely to contribute to the increased infiltration of monocytes into the aorta of Apoe −/− Mc1r e/e mice. Taken together, deficiency of MC1-R resulted in lower number of splenic Ly6C high monocytes, which were appearing in higher frequency in the aorta and giving probably rise to increased macrophage accumulation during the onset of atherosclerosis.
Deficiency of MC1-R Does Not Modify the Expression of Endothelial Adhesion Molecules in the Aorta
To dissect the underlying mechanism leading to increased monocyte entry to the aorta, we first investigated whether MC1-R deficiency aggravates endothelial inflammation, thus reinforcing monocyte adhesion and migration. Because the immunophenotype of Apoe −/− Mc1r e/e mice was more prominent without HFD, we focused on studying mice on chow diet in subsequent experiments. Flow cytometric analysis of aortic endothelial cells indicated no genotype-dependent difference in terms of the expression of VCAM-1 (vascular cell adhesion molecule 1), ICAM-1 (intercellular adhesion molecule 1), PECAM-1 (platelet and endothelial cell adhesion molecule 1), or P-selectin ( Figure 5A and 5B). Furthermore, when lysing the whole aorta and performing qPCR analysis of the same adhesion molecules, we observed no significant mRNA changes in the aorta of Apoe −/− Mc1r e/e mice compared with control group ( Figure 5C ). Immunostaining of aortic roots further revealed similar expression of VCAM-1, which mediates rolling and firm adhesion of Ly6C high to endothelial cells during atherogenesis 19 ( Figure 5D ). Collectively, these data suggest that the increased accumulation of Ly6C high monocytes in MC1-R-deficient mice is not relying on enhanced activation of the aortic endothelium.
Monocytes From Apoe −/− Mc1r e/e Mice Express Higher Levels of CD62L and PSGL-1
We next sought to explore whether MC1-R deficiency modifies the characteristics of monocytes because no apparent difference was noted in the endothelial cells. Previous studies have shown that Ly6C high and Ly6C low use different chemokines and their corresponding receptors to access sites of atherosclerosis, among which CCR2 (C-C chemokine receptor type 2), CCR5 (C-C chemokine receptor type 5), and CX 3 CR1 (C-X3-C motif chemokine receptor 1) are the key receptors because blocking any of these receptors reduces monocyte recruitment and combined receptor blockage almost abolishes atherosclerosis. 20, 21 We therefore measured the mRNA expression of these receptors in flow-sorted splenic Ly6C high and Ly6C low monocytes ( Figure 6A ). As expected, Ccr2 expression was upregulated in Ly6C high monocytes compared with their Ly6C low counterparts, whereas Ccr2 mRNA level was significantly lower in Apoe −/− Mc1r e/e mice ( Figure 6B ). No differences were noted in Ccr5 or Cx 3 cr1 expression ( Figure 6B ).
Murine Ly6C high monocytes also express L-selectin (CD62L), PSGL-1 (P-selectin glycoprotein ligand 1), LFA-1 (lymphocyte function-associated antigen 1), and VLA-4 (very late antigen 4), which all contribute to monocyte adhesion to activated endothelium. [22] [23] [24] Quantification of these adhesion molecules by flow cytometry revealed that Ly6C high monocytes from MC1-R-deficient mice express higher levels of CD62L and PSGL-1 ( Figure 6C and 6D) . Conversely, Ly6C low monocytes from the same mice showed reduced expression of CD18 ( Figure IX in the online-only Data Supplement), which together with CD11a forms the integrin LFA-1. CD49d, which is part of the integrin complex of VLA-4, was unaffected by MC1-R deficiency ( Figure IX in the online-only Data Supplement). In addition, determination of integrin-binding activity by incubating monocytes with soluble VCAM-1 fragments demonstrated distinct effects for MC1-R deficiency. Specifically, stimulation with CCL2 unveiled that Ly6C high monocytes from MC1-Rdeficient mice have slightly but significantly increased binding affinity for VCAM-1 ( Figure 6E and 6F) . Overall, these data indicate that MC1-R deficiency modifies the adhesion properties of classical monocytes mainly by increasing CD62L and PSGL-1 expression.
Discussion
The present study demonstrates a critical role for MC1-R in the development of atherosclerosis. First, we showed that deficiency in MC1-R signaling accelerates atherosclerosis and formation of more vulnerable plaques and worsens dietinduced hypercholesterolemia. Second, we identified that MC1-R regulates arterial accumulation of classical Ly6C high monocytes by modulating L-selectin and PSGL-1 expression.
We recently identified that MC1-R enhances cholesterol efflux from macrophages by upregulating Abca1 and Abcg1 expression. 12 These effects translated into therapeutic benefits when atherosclerotic Apoe −/− mice were treated with a selective MC1-R agonist. Although no effect was noted in terms of lesion size during early atherosclerosis, MC1-R activation promoted signs of plaque stability with increased α-SMA expression and collagen deposition. Herein, we characterized the plaque phenotype of Apoe −/− Mc1r e/e mice and were able to corroborate our previous findings. These mice with deficient MC1-R displayed a reverse phenotype with reduced Abca1 and Abcg1 expression and downregulation of α-SMA and Col3a1. Remarkably, MC1-R deficiency accelerated plaque formation and expanded necrotic core size in the lesions, a central characteristic of vulnerable plaques. The precise mechanisms leading to the exaggerated formation of necrotic cores in Apoe −/− Mc1r e/e mice are currently unknown, but reduced Abca1 and Abcg1 expression might be a significant contributing factor. Combined deficiency of Abca1 and Abcg1 has been unequivocally linked to enhanced atherosclerosis and formation of more complex plaques. 14, 16 This phenotype can be even recapitulated in the absence of enhanced monocytosis and expansion of hematopoietic stem cells, effects that typically arise when Abca1 and Abcg1 are uniformly deleted in myeloid cells. 14, 15, 25 This is evidenced by increased atherosclerosis in mice with macrophage-specific deficiency of ABCA1 and ABCG1. 26 Therefore, the reduced Abca1 and Abcg1 expression in MC1-R-deficient mice might impair the cholesterol handling of lesional macrophages and amplify inflammatory responses, the net outcome of which would be the formation of more complex plaques. Importantly, the current findings highlight that the integrity of MC1-R is an important determinant of plaque vulnerability.
Aside from the plaque phenotype, we observed increased plasma LDL/VLDL cholesterol levels and hepatic cholesterol accumulation in MC1-R-deficient mice, which, in turn, accelerates atherosclerosis. This strengthens our previous finding of reduced plasma LDL/VLDL cholesterol as a therapeutic response to MC1-R activation and further consolidates that MC1-R signaling is involved in the control of circulating cholesterol. 12 In the quest of causal factors for the elevated plasma cholesterol, we found that bile acid metabolism was disturbed in Apoe −/− Mc1r e/e mice. Because bile acid synthesis accounts for a major fraction of daily cholesterol turnover, it is conceivable that the disturbed bile acid metabolism is linked with hypercholesterolemia. Apoe −/− Mc1r e/e mice showed a distinct phenotype with reduced primary and increased secondary bile acid levels. Taking into account that ≈95% of bile acids are reabsorbed in the ileum and that this process is strictly regulated, it is possible that Apoe −/− Mc1r e/e mice are recycling more bile acids without significant replenishment by de novo synthesis, which then increases the amount of secondary bile acids. Unfortunately, we were unable to pinpoint the exact molecular-level mechanism for this phenotype, but it might involve changes in the biotransformation and absorption of bile acids in the gut. In parallel with the change in bile acid metabolism, Abcg5 and Abcg8 mRNA levels were upregulated Previous studies have demonstrated that human and mouse monocytes express functional MC1-R, 9, 27, 28 but the effects of this receptor on monocyte production and trafficking are largely unknown. We therefore immunophenotyped the Apoe −/− Mc1r e/e mouse model to explore whether MC1-R deficiency affects homeostatic monocyte counts within tissues and circulation. We observed that blood Ly6C high monocyte count was unchanged in Apoe −/− Mc1r e/e mice compared with control group, whereas the splenic pool of this subset was reduced with the concurrent appearance of higher cell number in the aorta. These data imply that the circulating classical monocytes were in equilibrium and that the reservoir of these cells in the spleen was mobilized to fuel the enhancement of arterial monocyte accumulation in MC1-R-deficient mice. These events occurred without evidence of increased mobilization from the bone marrow. After 4-week HFD, monocyte production was augmented in the bone marrow of Apoe
e/e mice. This could be linked to the observed increase in plasma cholesterol levels rather than to the reduction of bone marrow Abcg1 expression because only combined deficiency of ABCA1 and ABCG1 is likely to accelerate myeloid monocyte production. 25, 26 Strikingly, however, HFD induced blood monocytosis equally in both genotypes, but led to a slight increase in aortic monocyte and macrophage accumulation only in control mice. Accordingly, MC1-R deficiency seems to affect tissue monocyte counts more drastically in chow-fed conditions, when dietary cholesterol is not producing an overwhelming trigger for monocytosis and arterial leukocyte accumulation. Defective MC1-R signaling might therefore accelerate monocyte recruitment specifically during the early phases of atherosclerosis. Monocyte influx and differentiation indeed dictate macrophage accumulation in early atherosclerosis, 3, 4, 20, 29 whereas in more advanced lesions, replenishment of macrophages is predominantly dependent on local proliferation. 30 The current finding of increased monocyte accumulation in the aorta of MC1-R-deficient mice is well in line with our recent study, where pharmacological activation of MC1-R elicited an opposite effect, that is, reduced monocyte accumulation. 12 In addition, chronic MC1-R treatment led to an increase in circulating Ly6C 31 one possible explanation for these findings is that the increased arterial accumulation of Ly6C high monocytes is compromising the conversion of these cells into Ly6C low monocytes and thus reducing their number in the blood. We also found that Ly6C low monocytes of MC1-R-deficient mice express less CD18, which is part of the LFA-1 integrin complex and contributes to the patrolling behavior of these cells. These notions warrant further research to investigate the significance and mechanisms of this MC1-R-driven modulation of blood Ly6C low monocyte count. Monocytes and particularly classical Ly6C high monocytes accumulate within atherosclerotic lesions through a process that is regulated at multiple levels, for example, mobilization from sites of production, recruitment, and life span in the lesions. Recruitment and consequent extravasation require coordinated actions of chemokines and their receptors and selectins and adhesion molecules. It was previously postulated that CCR2, CCR5, and CX 3 CR1 are fundamental mediators of monocyte chemotaxis to inflamed arteries, 20, 21 but a recent study highlighted the importance of CCR1 and CCR5 over CCR2 and CX 3 CR1 in monocyte recruitment. 32 Although classical monocyte recruitment to atherosclerotic lesions does not require CCR2, it has an important role in monocyte mobilization from the bone marrow. Consequently, we were interested to screen the expression of these receptors in classical monocytes of MC1-R-deficient mice. Surprisingly, we found reduced monocyte Ccr2 expression, although the mice displayed normal circulating monocyte counts, but elevated plasma CCL2 levels and increased Ly6C high monocyte accumulation in the aorta. We may only speculate that Ccr2 might be downregulated as a compensatory mechanism in the presence of excess CCL2 or that other recruitment pathways are dominating and damping its expression. In light of this possibility, we analyzed the expression of adhesion molecules that are major determinants of monocyte trafficking and entry to sites of atherosclerosis. Ly6C high monocytes of MC1-R-deficient mice showed increased levels of CD62L and PSGL-1, the latter of which is especially crucial in the recruitment of Ly6C high monocytes and has a significant impact on atherosclerosis susceptibility. 22, 33, 34 Furthermore, despite that MC1-R deficiency did not affect CD49d expression, we found that the integrin dimer VLA-4, which is composed of CD49d and CD29 and forms a binding partner with VCAM-1, was functionally more active in the Ly6C high monocytes of MC1-R-deficient mice as evidenced by increased binding to soluble VCAM-1. The interaction between VLA-4 and VCAM-1 regulates monocyte adhesion to inflamed endothelium, 19, 35 thus giving another mechanistic explanation for increased arterial monocyte accumulation in MC1-R-deficient mice. Collectively, these data give a new perspective on the role of MC1-R in controlling monocyte recruitment and adhesion molecule expression during atherogenesis.
In conclusion, our data establish the impact of MC1-R on atheroprogression by demonstrating that its dysfunction exacerbates atherosclerosis and plaque vulnerability. The acceleration of atherosclerosis is likely driven by disturbed cholesterol conversion into bile acids and the consequent increase of plasma cholesterol levels. The disturbed cholesterol and bile acid metabolism in MC1-R-deficient mice are the key findings of this study that merit further research to investigate the exact mechanism by which MC1-R regulates cholesterol metabolism.
